Literature DB >> 9527559

The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: the effect of doxycycline and chemically modified tetracycline.

N Y Karimbux1, N S Ramamurthy, L M Golub, I Nishimura.   

Abstract

Tissue remodeling is a dynamic state in which a balance is achieved between the proteolytic breakdown and synthesis of the extracellular matrix. Type I collagen is a major component of the gingival connective tissue (GCT) and the periodontal ligament (PDL) throughout development, while type XII collagen has been found in the mature forms of these tissues. The purpose of this study was to investigate the effects of periodontitis on the expression of type I and XII collagen and subsequently to investigate the effects of doxycycline (DOXY) and chemically modified non-antimicrobial tetracycline (CMT-1) on the expression of these molecules in this model. Adult barrier-raised male Sprague-Dawley rats were inoculated with Porphyromonas gingivalis obtained from humans to create the experimental periodontitis. The animals with the P. gingivalis-induced periodontitis were then split into the following groups: Group A served as infected untreated controls (PGI group); group B was treated with doxycycline (DOXY group); and group C was treated with chemically modified tetracycline-1 (CMT-1 group). Group D contained uninfected animals that served as uninfected controls (NIC group). The expression of type I and XII collagen mRNAs was examined by in situ hybridization in each group, with the co-expression of these molecules representing mature and functional gingival connective tissue. In the NIC group, cells hybridized with digoxygenine-labeled cDNA probes encoding rat alpha2(I) or alpha1(XII) collagens were found distributed uniformly throughout the periodontal connective tissue. The PGI group showed little hybridization in the areas of infection, while both the DOXY and CMT-1 groups showed co-expression of the alpha2(I) and alpha1(XII) probes in the GCT and coronal part of the PDL. This study demonstrates that doxycycline and CMT-1 moderate or reduce the inhibitory effects of periodontal infection on the expression of type I and type XII collagen mRNAs. These results suggest that doxycycline and a form of non-antimicrobial tetracycline, chemically modified tetracycline-1, can reduce periodontal destruction by reversing the inhibitory effect of periodontal infection on collagen synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527559     DOI: 10.1902/jop.1998.69.1.34

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis.

Authors:  Jill E Rogers; Fei Li; Derek D Coatney; Carlos Rossa; Paul Bronson; Jaclynn M Krieder; William V Giannobile; Keith L Kirkwood
Journal:  J Periodontol       Date:  2007-03       Impact factor: 6.993

2.  A bacterial-biofilm-induced oral osteolytic infection can be successfully treated by immuno-targeting an extracellular nucleoid-associated protein.

Authors:  M O Freire; A Devaraj; A Young; J B Navarro; J S Downey; C Chen; L O Bakaletz; H H Zadeh; S D Goodman
Journal:  Mol Oral Microbiol       Date:  2016-04-05       Impact factor: 3.563

3.  Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice.

Authors:  Rafael Scaf de Molon; Vinicius Ibiapina Mascarenhas; Erica Dorigatti de Avila; Livia Sertori Finoti; Gustavo Boze Toffoli; Denise Madalena Palomari Spolidorio; Raquel Mantuaneli Scarel-Caminaga; Sotirios Tetradis; Joni Augusto Cirelli
Journal:  Clin Oral Investig       Date:  2015-09-28       Impact factor: 3.573

4.  Periodontitis in rats induces systemic oxidative stress that is controlled by bone-targeted antiresorptives.

Authors:  Sehkar Oktay; Sasanka S Chukkapalli; Mercedes F Rivera-Kweh; Irina M Velsko; L Shannon Holliday; Lakshmyya Kesavalu
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

5.  Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis.

Authors:  Rupali Agnihotri; Sumit Gaur
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

6.  Bis-enoxacin blocks rat alveolar bone resorption from experimental periodontitis.

Authors:  Mercedes F Rivera; Sasanka S Chukkapalli; Irina M Velsko; Ju-Youn Lee; Indraneel Bhattacharyya; Calogero Dolce; Edgardo J Toro; L Shannon Holliday; Lakshmyya Kesavalu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

7.  Synthesis of a Novel Electrospun Polycaprolactone Scaffold Functionalized with Ibuprofen for Periodontal Regeneration: An In Vitro andIn Vivo Study.

Authors:  Fareeha Batool; David-Nicolas Morand; Lionel Thomas; Isaac Maximiliano Bugueno; Javier Aragon; Silvia Irusta; Laetitia Keller; Nadia Benkirane-Jessel; Henri Tenenbaum; Olivier Huck
Journal:  Materials (Basel)       Date:  2018-04-10       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.